{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) } Pack [Lojaimiess 91 Day]
- RxCUI
- 2117770
- RxNorm name
- {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) } Pack [Lojaimiess 91 Day]
- Display name
- LOJAIMIESS 91 DAY (Pack)
- Full name
- {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) } Pack [Lojaimiess 91 Day]
- Term type
- BPCK
- Status
- Active
- Strength
- mixed
- Dose form
- Pack
- Route
- Pack
- Updated
- 2026-11-16 22:44:47
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 032019
- Active start
- 032019
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| ethinyl estradiol | 0.02 MG / 1 EACH | ethinyl estradiol | ethinyl estradiol |
| ethinyl estradiol | 0.01 MG / 1 EACH | ethinyl estradiol | ethinyl estradiol |
| levonorgestrel | 0.1 MG / 1 EACH | levonorgestrel | levonorgestrel |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Pack | 746839 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| ethinyl estradiol | 4124 |
| levonorgestrel | 6373 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Lojaimiess 91 Day Pack | 1 | NAMES |
| RxNorm Name | {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) } Pack [Lojaimiess 91 Day] | 1 | NAMES |
| RxNorm Synonym | Lojaimiess 91 Day Pack | 1 | NAMES |
| TTY | BPCK | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 2117770 | 1 | CODES |
| MMSL_CODE | BD24722 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 70700-124-87 | 70700-124 | LoJaimiess levonorgestrel/ethinyl estradiol and ethinyl estradiol | Xiromed, LLC. | ANDA205131 |
| 70700-207-93 | 70700-207 | LOJAIMIESS Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol tablets | Xiromed LLC | ANDA200493 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA205131 | 70700-124 | LoJaimiess levonorgestrel/ethinyl estradiol and ethinyl estradiol | ANDA | Xiromed, LLC. |
| ANDA200493 | 70700-207 | LOJAIMIESS Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol tablets | ANDA | Xiromed LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LOJAIMIESS | LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL TABLETS | Xiromed LLC | 2a20c571-59c7-cadf-dcf7-1b4707c661a3 | 2024-09-16 | Boxed warning, Warnings, Adverse reactions | 70700-207-93 70700-207 70700020793 70700020787 2117770 |
| LoJaimiess | LEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | Xiromed, LLC. | 5f0b397c-256a-0163-35c7-e9401705b439 | 2024-02-12 | Boxed warning, Warnings, Adverse reactions | 70700-124-87 70700-124 70700012487 2117770 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5f0b397c-256a-0163-35c7-e9401705b439 | {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) } Pack [Lojaimiess 91 Day] [BPCK] · LoJaimiess 91 Day Pack [PSN] · Lojaimiess 91 Day Pack [SY] | 3 | 101 | These highlights do not include all the information needed to use LOJAIMIESS safely and effectively. See full prescribing information for LOJAIMIESS. LOJAIMIESS® (levonorgestrel and ethinyl estradiol tablets, USP and ethinyl estradiol tablets, USP), for oral use Initial U.S. Approval: 1982 | 20240212 |
| 2a20c571-59c7-cadf-dcf7-1b4707c661a3 | {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) } Pack [Lojaimiess 91 Day] [BPCK] · LoJaimiess 91 Day Pack [PSN] · Lojaimiess 91 Day Pack [SY] | 3 | 1 | These highlights do not include all the information needed to use LOJAIMIESS safely and effectively. See full prescribing information for LOJAIMIESS. LOJAIMIESS ® (levonorgestrel and ethinyl estradiol tablets and ethinyl estradiol tablets), for oral use Initial U.S. Approval: 1982 | 20240916 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 2a20c571-59c7-cadf-dcf7-1b4707c661a3 | These highlights do not include all the information needed to use LOJAIMIESS safely and effectively. See full prescribing information for LOJAIMIESS. LOJAIMIESS ® (levonorgestrel and ethinyl estradiol tablets and ethinyl estradiol tablets), for oral use Initial U.S. Approval: 1982 | Xiromed LLC | 20240916 |
| 5f0b397c-256a-0163-35c7-e9401705b439 | These highlights do not include all the information needed to use LOJAIMIESS safely and effectively. See full prescribing information for LOJAIMIESS. LOJAIMIESS® (levonorgestrel and ethinyl estradiol tablets, USP and ethinyl estradiol tablets, USP), for oral use Initial U.S. Approval: 1982 | Xiromed, LLC. | XIROMED PHARMA ESPANA, S.L. | Laboratorios León Farma, S.A. | 20240212 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | G03AD | Emergency contraceptives | ATC1-4 | levonorgestrel | |
| ATC | L02AA | Estrogens | ATC1-4 | ethinyl estradiol | |
| ATC | G03CA | Natural and semisynthetic estrogens, plain | ATC1-4 | ethinyl estradiol | |
| ATC | G03AC | Progestogens | ATC1-4 | levonorgestrel | |
| ATC | G03AA | Progestogens and estrogens, fixed combinations | ATC1-4 | ethinyl estradiol / levonorgestrel | |
| ATC | G03AB | Progestogens and estrogens, sequential preparations | ATC1-4 | ethinyl estradiol / levonorgestrel | |
| FDASPL | D045167 | Progesterone Congeners | CHEM | has_chemical_structure | levonorgestrel |
| FDASPL | N0000175825 | Estrogen | EPC | has_epc | ethinyl estradiol |
| FDASPL | N0000175602 | Progestin | EPC | has_epc | levonorgestrel |
| FDASPL | N0000175832 | Progestin-containing Intrauterine System | EPC | has_epc | levonorgestrel |
| FDASPL | N0000000100 | Estrogen Receptor Agonists | MOA | has_moa | ethinyl estradiol |
| FDASPL | N0000175830 | Inhibit Ovum Fertilization | PE | has_pe | levonorgestrel |
| MEDRT | D004997 | Ethinyl Estradiol | CHEM | has_ingredient | ethinyl estradiol |
| MEDRT | D016912 | Levonorgestrel | CHEM | has_ingredient | levonorgestrel |
| MEDRT | D000022 | Abortion, Spontaneous | DISEASE | induces | levonorgestrel |
| MEDRT | D018248 | Adenoma, Liver Cell | DISEASE | ci_with | levonorgestrel |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | levonorgestrel |
| MEDRT | D002539 | Cerebral Arterial Diseases | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D002561 | Cerebrovascular Disorders | DISEASE | ci_with | levonorgestrel |
| MEDRT | D003324 | Coronary Artery Disease | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D003327 | Coronary Disease | DISEASE | ci_with | levonorgestrel |
| MEDRT | D003920 | Diabetes Mellitus | DISEASE | ci_with | levonorgestrel |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | levonorgestrel |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | ci_with | levonorgestrel |
| MEDRT | D020773 | Headache Disorders | DISEASE | ci_with | levonorgestrel |
| MEDRT | D006349 | Heart Valve Diseases | DISEASE | ci_with | levonorgestrel |
| MEDRT | D019584 | Hot Flashes | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | levonorgestrel |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D007006 | Hypogonadism | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D007565 | Jaundice | DISEASE | ci_with | levonorgestrel |
| MEDRT | D007674 | Kidney Diseases | DISEASE | ci_with | levonorgestrel |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | levonorgestrel |
| MEDRT | D008113 | Liver Neoplasms | DISEASE | ci_with | levonorgestrel |
| MEDRT | D008594 | Menopause, Premature | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D008595 | Menorrhagia | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D015663 | Osteoporosis, Postmenopausal | DISEASE | may_prevent | ethinyl estradiol |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | ethinyl estradiol |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | levonorgestrel |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | levonorgestrel |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D016649 | Primary Ovarian Insufficiency | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D011471 | Prostatic Neoplasms | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D013923 | Thromboembolism | DISEASE | ci_with | levonorgestrel |
| MEDRT | D013923 | Thromboembolism | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | levonorgestrel |
| MEDRT | D064424 | Tobacco Use | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D014029 | Tobacco Use Disorder | DISEASE | ci_with | levonorgestrel |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | ci_with | levonorgestrel |
| MEDRT | N0000000100 | Estrogen Receptor Agonists | MOA | has_moa | ethinyl estradiol |
| MEDRT | N0000000185 | Progestational Hormone Receptor Agonists | MOA | has_moa | levonorgestrel |
| MEDRT | N0000008311 | Bone Formation Stimulation | PE | has_pe | ethinyl estradiol |
| MEDRT | N0000008595 | Decreased Embryonic Implantation | PE | has_pe | ethinyl estradiol |
| MEDRT | N0000008595 | Decreased Embryonic Implantation | PE | has_pe | levonorgestrel |
| MEDRT | N0000009072 | Hypothalamic Endocrine Activity Alteration | PE | has_pe | levonorgestrel |
| MEDRT | N0000178478 | Increased Blood Pressure | PE | ci_pe | levonorgestrel |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | ethinyl estradiol |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | levonorgestrel |
| MEDRT | N0000009902 | Vaginal Function Alteration | PE | has_pe | ethinyl estradiol |
| MEDRT | N0000008289 | Aromatic hydroxylation | PK | has_pk | ethinyl estradiol |
| MEDRT | N0000000045 | Fecal Excretion | PK | has_pk | ethinyl estradiol |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | ethinyl estradiol |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | ethinyl estradiol |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA200493 |
| CODES | ANDA | ANDA205131 |
| CODES | VUID | 4039232 |
| NAMES | Prescribable Synonym | LoJaimiess 91 Day Pack |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | Veterans Health Administration National Drug File |